{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T05:08:38Z","timestamp":1771650518832,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T00:00:00Z","timestamp":1601251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T00:00:00Z","timestamp":1601251200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["307611\/2018-3"],"award-info":[{"award-number":["307611\/2018-3"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2013\/08028-1"],"award-info":[{"award-number":["2013\/08028-1"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"name":"INCT-CETGEN","award":["573633\/2008-8"],"award-info":[{"award-number":["573633\/2008-8"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s12282-020-01165-1","type":"journal-article","created":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T15:03:41Z","timestamp":1601305421000},"page":"346-354","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Germline variants of Brazilian women with breast cancer and detection of a novel pathogenic ATM deletion in early-onset breast cancer"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4168-152X","authenticated-orcid":false,"given":"Gabriel","family":"Bandeira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katia","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monize","family":"Lazar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzana","family":"Ezquina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guilherme","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Varela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meire","family":"Aguena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomaz","family":"Gollop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayana","family":"Zatz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Rita","family":"Passos-Bueno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Krepischi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oswaldo Keith","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,28]]},"reference":[{"key":"1165_CR1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21492","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018. https:\/\/doi.org\/10.3322\/caac.21492.","journal-title":"CA Cancer J Clin"},{"key":"1165_CR2","unstructured":"INCA. 2020 https:\/\/www.inca.gov.br\/tipos-de-cancer\/cancer-de-mama. Accessed 25 Mar 2020"},{"key":"1165_CR3","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.65.0747","author":"N Tung","year":"2016","unstructured":"Tung N, Lin NU, Kidd J, Allen B, a, Singh, N., Wenstrup, R. J., Garber, J. E. Frequency of germline mutations in 25 cancer susceptibility genes in a sequential series of patients with breast cancer. J Clin Oncol. 2016. https:\/\/doi.org\/10.1200\/JCO.2015.65.0747.","journal-title":"J Clin Oncol"},{"key":"1165_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2016.72","author":"FC Nielsen","year":"2016","unstructured":"Nielsen FC, Van Overeem Hansen T, S\u00f8rensen CS. Hereditary breast and ovarian cancer: new genes in confined pathways. Nat Rev Cancer. 2016. https:\/\/doi.org\/10.1038\/nrc.2016.72.","journal-title":"Nat Rev Cancer"},{"key":"1165_CR5","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2018.2956","author":"HM Lu","year":"2019","unstructured":"Lu HM, Li S, Black MH, Lee S, Hoiness R, Wu S, Elliott A. Association of breast and ovarian cancers with predisposition genes identified by large-scale sequencing. JAMA Oncology. 2019. https:\/\/doi.org\/10.1001\/jamaoncol.2018.2956.","journal-title":"JAMA Oncology"},{"key":"1165_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11091246","author":"OM Catalan","year":"2019","unstructured":"Catalan OM, Campos-Parra AD, V\u00e1zquez-Romo R, De Le\u00f3n DC, Jacobo-Herrera N, Morales-Gonz\u00e1lez F, P\u00e9rez-Plasencia C. A multi-center study of BRCA1 and BRCA2 germline mutations in Mexican-Mestizo breast cancer families reveals mutations unreported in Latin American population. Cancers. 2019. https:\/\/doi.org\/10.3390\/cancers11091246.","journal-title":"Cancers"},{"key":"1165_CR7","unstructured":"Elizabeth S. Moving Universal Health Coverage from Ambition to Practice: focus on Brazil. The Economist. 2019;10. https:\/\/eiuperspectives.economist.com\/sites\/default\/files\/download\/country_profile_brazil_v4-final.pdf.\u00a0Accessed 23 Mar 2020"},{"key":"1165_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0187630","author":"B Alemar","year":"2017","unstructured":"Alemar B, Greg\u00f3rio C, Herzog J, Bittar CM, Netto BO, Artigalas C, Ashton-Prolla OP. BRCA1 and BRCA2 mutational profile and prevalence in hereditary breast and ovarian cancer (HBOC) probands from Southern Brazil: Are international testing criteria appropriate for this specific population? PLoS ONE. 2017. https:\/\/doi.org\/10.1371\/journal.pone.0187630.","journal-title":"PLoS ONE"},{"key":"1165_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0057581","author":"DM Carraro","year":"2013","unstructured":"Carraro DM, Koike Folgueira MAA, Garcia Lisboa BC, Ribeiro Olivieri EH, Vitorino Krepischi AC, de Carvalho AF, Brentani MM. Comprehensive analysis of BRCA1, BRCA2 and tp53 germline mutation and tumor characterization: a portrait of early-onset breast cancer in Brazil. PLoS ONE. 2013. https:\/\/doi.org\/10.1371\/journal.pone.0057581.","journal-title":"PLoS ONE"},{"key":"1165_CR10","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.12610","author":"GC Fernandes","year":"2016","unstructured":"Fernandes GC, Michelli RAD, Galv\u00e3o HCR, Paula AE, Pereira R, Andrade CE, Palmero EI. Prevalence of BRCA1\/BRCA2 mutations in a Brazilian population sample at-risk for hereditary breast cancer and characterization of its genetic ancestry. Oncotarget. 2016. https:\/\/doi.org\/10.18632\/oncotarget.12610.","journal-title":"Oncotarget"},{"key":"1165_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-27315-2","author":"EI Palmero","year":"2018","unstructured":"Palmero EI, Carraro DM, Alemar B, Moreira MAM, Ribeiro-Dos-Santos \u00c2, Abe-Sandes K, Ashton-Prolla P. The germline mutational landscape of BRCA1 and BRCA2 in Brazil. Sci Rep. 2018. https:\/\/doi.org\/10.1038\/s41598-018-27315-2.","journal-title":"Sci Rep"},{"issue":"1","key":"1165_CR12","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12920-019-0652-y","volume":"13","author":"S da Costa e Silva Carvalho","year":"2020","unstructured":"da Costa e Silva Carvalho S, Cury NM, Brotto DB, de Araujo LF, Rosa RCA, Texeira LA, Silva WA Jr. Germline variants in DNA repair genes associated with hereditary breast and ovarian cancer syndrome: analysis of a 21 gene panel in the Brazilian population. BMC Med Genom. 2020;13(1):21. https:\/\/doi.org\/10.1186\/s12920-019-0652-y.","journal-title":"BMC Med Genom"},{"key":"1165_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-018-4938-0","author":"AR de Souza Timoteo","year":"2018","unstructured":"de Souza Timoteo AR, Gon\u00e7alves A\u00c9MM, Sales LAP, Albuquerque BM, de Souza JES, de Moura PCP, Lajus TBP. A portrait of germline mutation in Brazilian at-risk for hereditary breast cancer. Breast Cancer Res Treat. 2018. https:\/\/doi.org\/10.1007\/s10549-018-4938-0.","journal-title":"Breast Cancer Res Treat"},{"issue":"15_suppl","key":"1165_CR14","doi-asserted-by":"publisher","first-page":"e13610","DOI":"10.1200\/jco.2018.36.15_suppl.e13610","volume":"36","author":"RSC Guindalini","year":"2018","unstructured":"Guindalini RSC, Viana D, Kitajima JP, Valim A, Schlesinger D, Kok F, Koike Folgueira MAA. Detection of inherited mutations in Brazilian breast cancer patients using multi-gene panel testing. J Clin Oncol. 2018;36(15_suppl):e13610. https:\/\/doi.org\/10.1200\/jco.2018.36.15_suppl.e13610.","journal-title":"J Clin Oncol"},{"key":"1165_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2350-15-55","author":"FC Silva","year":"2014","unstructured":"Silva FC, Lisboa BCG, Figueiredo MCP, Torrezan GT, Santos \u00c9MM, Krepischi AC, Carraro DM. Hereditary breast and ovarian cancer: assessment of point mutations and copy number variations in Brazilian patients. BMC Med Genet. 2014. https:\/\/doi.org\/10.1186\/1471-2350-15-55.","journal-title":"BMC Med Genet"},{"key":"1165_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2018.00161","author":"GT Torrezan","year":"2018","unstructured":"Torrezan GT, de Almeida FG, de Figueiredo SR, Barros BDDF, de Paula CAA, Valieris CAAR, Carraro DM. Complex landscape of germline variants in Brazilian patients with hereditary and early onset breast cancer. Front Genet. 2018. https:\/\/doi.org\/10.3389\/fgene.2018.00161.","journal-title":"Front Genet"},{"key":"1165_CR17","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btp324","author":"H Li","year":"2009","unstructured":"Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009. https:\/\/doi.org\/10.1093\/bioinformatics\/btp324.","journal-title":"Bioinformatics"},{"key":"1165_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/0471250953.bi1110s43","author":"GA Van der Auwera","year":"2013","unstructured":"Van der Auwera GA, Carneiro MO, Hartl C, Poplin R, del Angel G, Levy-Moonshine A, DePristo MA. From fastQ data to high-confidence variant calls: the genome analysis toolkit best practices pipeline. Curr Protoc Bioinform. 2013. https:\/\/doi.org\/10.1002\/0471250953.bi1110s43.","journal-title":"Curr Protoc Bioinform"},{"key":"1165_CR19","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkq603","author":"K Wang","year":"2010","unstructured":"Wang K, Li M, Hakonarson H. ANNOVAR: Functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010. https:\/\/doi.org\/10.1093\/nar\/gkq603.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"1165_CR20","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Rehm HL. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405\u201324. https:\/\/doi.org\/10.1038\/gim.2015.30.","journal-title":"Genet Med"},{"key":"1165_CR21","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdr304","author":"A Goldhirsch","year":"2011","unstructured":"Goldhirsch A, Wood WC, Coates AS, Gelber RD, Th\u00fcrlimann B, Senn HJ. Strategies for subtypes-dealing with the diversity of breast cancer: Highlights of the St Gallen international expert consensus on the primary therapy of early breast cancer 2011. Ann Oncol. 2011. https:\/\/doi.org\/10.1093\/annonc\/mdr304.","journal-title":"Ann Oncol"},{"issue":"4","key":"1165_CR22","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1200\/JCO.2014.57.1414","volume":"33","author":"FJ Couch","year":"2015","unstructured":"Couch FJ, Hart SN, Sharma P, Toland AE, Wang X, Miron P, Fasching PA. Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer. J Clin Oncol. 2015;33(4):304\u201311. https:\/\/doi.org\/10.1200\/JCO.2014.57.1414.","journal-title":"J Clin Oncol"},{"key":"1165_CR23","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.7027","author":"PH Lin","year":"2016","unstructured":"Lin PH, Kuo WH, Huang AC, Lu YS, Lin CH, Kuo SH, Huang CS. Multiple gene sequencing for risk assessment in patients with early-onset or familial breast cancer. Oncotarget. 2016. https:\/\/doi.org\/10.18632\/oncotarget.7027.","journal-title":"Oncotarget"},{"key":"1165_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31601","author":"JY Li","year":"2019","unstructured":"Li JY, Jing R, Wei H, Wang M, Xiaowei Q, Liu H, Jiang J. Germline mutations in 40 cancer susceptibility genes among Chinese patients with high hereditary risk breast cancer. Int J Cancer. 2019. https:\/\/doi.org\/10.1002\/ijc.31601.","journal-title":"Int J Cancer"},{"key":"1165_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-016-2966-x","author":"S Maistro","year":"2016","unstructured":"Maistro S, Teixeira N, Encinas G, Katayama MLH, Niewiadonski VDT, Cabral LG, Folgueira MAAK. Germline mutations in BRCA1 and BRCA2 in epithelial ovarian cancer patients in Brazil. BMC Cancer. 2016. https:\/\/doi.org\/10.1186\/s12885-016-2966-x.","journal-title":"BMC Cancer"},{"key":"1165_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2007.10.044","author":"EI Palmero","year":"2008","unstructured":"Palmero EI, Sch\u00fcler-Faccini L, Caleffi M, Achatz MIW, Olivier M, Martel-Planche G, Ashton-Prolla P. Detection of R337H, a germline TP53 mutation predisposing to multiple cancers, in asymptomatic women participating in a breast cancer screening program in Southern Brazil. Cancer Lett. 2008. https:\/\/doi.org\/10.1016\/j.canlet.2007.10.044.","journal-title":"Cancer Lett"},{"key":"1165_CR27","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.46.3711","author":"G Cust\u00f3dio","year":"2013","unstructured":"Cust\u00f3dio G, Parise GA, Filho NK, Komechen H, Sabbaga CC, Rosati R, Figueiredo BC. Impact of neonatal screening and surveillance for the TP53 R337H mutation on early detection of childhood adrenocortical tumors. J Clin Oncol. 2013. https:\/\/doi.org\/10.1200\/JCO.2012.46.3711.","journal-title":"J Clin Oncol"},{"key":"1165_CR28","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-2727","author":"I Hickson","year":"2004","unstructured":"Hickson I, Zhao Y, Richardson CJ, Green SJ, Martin NMB, Orr AI, Smith GCM. Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM. Can Res. 2004. https:\/\/doi.org\/10.1158\/0008-5472.CAN-04-2727.","journal-title":"Can Res"},{"key":"1165_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2013.00037","author":"TH Stracker","year":"2013","unstructured":"Stracker TH, Roig I, Knobel PA, Marjanovi\u0107 M. The ATM signaling network in development and disease. Front Genet. 2013. https:\/\/doi.org\/10.3389\/fgene.2013.00037.","journal-title":"Front Genet"},{"key":"1165_CR30","first-page":"A344","volume":"23","author":"M Swift","year":"1975","unstructured":"Swift M, Sholman L, Perry M, Chase C. Malignant neoplasm in ataxia telangiectasia families. Clin Res. 1975;23:A344\u20134.","journal-title":"Clin Res."},{"key":"1165_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2019.07.002","author":"MH Jin","year":"2019","unstructured":"Jin MH, Oh DY. ATM in DNA repair in cancer. Pharmacol Ther. 2019. https:\/\/doi.org\/10.1016\/j.pharmthera.2019.07.002.","journal-title":"Pharmacol Ther"},{"key":"1165_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/gepi.21971","author":"M Marabelli","year":"2016","unstructured":"Marabelli M, Cheng SC, Parmigiani G. Penetrance of ATM gene mutations in breast cancer: a meta-analysis of different measures of risk. Genet Epidemiol. 2016. https:\/\/doi.org\/10.1002\/gepi.21971.","journal-title":"Genet Epidemiol"},{"key":"1165_CR33","first-page":"3325","volume":"63","author":"YR Thorstenson","year":"2003","unstructured":"Thorstenson YR, Roxas A, Kroiss R, Jenkins MA, Yu KM, Bachrich T, Oefner PJ. Contributions of ATM mutations to familial breast and ovarian cancer. Cancer Res. 2003;63:3325\u201333.","journal-title":"Cancer Res"},{"key":"1165_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3342","author":"H Helgason","year":"2015","unstructured":"Helgason H, Rafnar T, Olafsdottir HS, Jonasson JG, Sigurdsson A, Stacey SN, Stefansson K. Loss-of-function variants in ATM confer risk of gastric cancer. Nat Genet. 2015. https:\/\/doi.org\/10.1038\/ng.3342.","journal-title":"Nat Genet"},{"key":"1165_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00909","author":"H Chen","year":"2018","unstructured":"Chen H, Wu J, Zhang Z, Tang Y, Li X, Liu S, Li X. Association between BRCA status and triple-negative breast cancer: a meta-analysis. Front Pharmacol. 2018. https:\/\/doi.org\/10.3389\/fphar.2018.00909.","journal-title":"Front Pharmacol"},{"key":"1165_CR36","volume-title":"Breast cancer facts & figures 2019\u20132020","author":"American Cancer Society","year":"2019","unstructured":"American Cancer Society. Breast cancer facts & figures 2019\u20132020. Atlanta: American Cancer Society; 2019."},{"issue":"6","key":"1165_CR37","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.amepre.2017.01.027","volume":"52","author":"F Guo","year":"2017","unstructured":"Guo F, Hirth JM, Lin YL, Richardson G, Levine L, Berenson AB, Kuo YF. Use of BRCA mutation test in the U.S., 2004\u20132014. Am J Prev Med. 2017;52(6):702\u20139. https:\/\/doi.org\/10.1016\/j.amepre.2017.01.027.","journal-title":"Am J Prev Med"},{"key":"1165_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/ng1837","author":"A Renwick","year":"2006","unstructured":"Renwick A, Thompson D, Seal S, Kelly P, Chagtai T, Ahmed M, Rahman N. ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles. Nat Genet. 2006. https:\/\/doi.org\/10.1038\/ng1837.","journal-title":"Nat Genet"},{"key":"1165_CR39","doi-asserted-by":"publisher","DOI":"10.1089\/dna.2013.1970","author":"FF Han","year":"2013","unstructured":"Han FF, Guo CL, Liu LH. The effect of CHEK2 variant I157T on cancer susceptibility: evidence from a meta-analysis. DNA Cell Biol. 2013. https:\/\/doi.org\/10.1089\/dna.2013.1970.","journal-title":"DNA Cell Biol"},{"key":"1165_CR40","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddi052","author":"A Shaag","year":"2005","unstructured":"Shaag A, Walsh T, Renbaum P, Kirchhoff T, Nafa K, Shiovitz S, King MC. Functional and genomic approaches reveal an ancient CHEK2 allele associated with breast cancer in the Ashkenazi Jewish population. Hum Mol Genet. 2005. https:\/\/doi.org\/10.1093\/hmg\/ddi052.","journal-title":"Hum Mol Genet"}],"container-title":["Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-020-01165-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12282-020-01165-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-020-01165-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T00:20:37Z","timestamp":1632788437000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12282-020-01165-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,28]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["1165"],"URL":"https:\/\/doi.org\/10.1007\/s12282-020-01165-1","relation":{},"ISSN":["1340-6868","1880-4233"],"issn-type":[{"value":"1340-6868","type":"print"},{"value":"1880-4233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,28]]},"assertion":[{"value":"26 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest\/Competing interests"}},{"value":"This study was approved by the Research and Ethics Committee of the Institute of Biosciences of the University of S\u00e3o Paulo.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}